AbbVie
ABBV
#25
Rank
โ‚ฌ461.39 B
Marketcap
261,02ย โ‚ฌ
Share price
1.01%
Change (1 day)
29.34%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of November 2026 (TTM): 7.74

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -86.7. At the end of 2026 the company had a P/S ratio of 7.04.

P/S ratio history for AbbVie from 2012 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20267.046.17%
20256.6318.67%
20245.5810.86%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.47-68.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
13.9 80.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.10-21.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
3.59-53.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6.74-12.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.42-68.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.37-43.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.16-72.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
4.19-45.79%๐Ÿ‡บ๐Ÿ‡ธ USA